Wos Açık Erişimli Yayınlar
Permanent URI for this collectionhttps://hdl.handle.net/11727/10754
Browse
79 results
Search Results
Item Correlations Between Problem Domain and Solution Domain Size Measures for Open Source Software(2014) Ayyildiz, Tulin Ercelebi; Kocyigit, Altan; https://orcid.org/0000-0002-7372-0223; AAE-1726-2021Predicting how much effort will be required to complete a software project as early as possible is a very important factor in the success of software development projects. Including function points and its variants, there are several size measures and corresponding measurement methods that can be used for effort estimation. However, in most of the projects, there is limited amount of information available in the early stages and significant effort is spent for size measurement and effort estimation with such methods. This paper analyzes the correlation between the size metrics of conceptual model of the problem domain and the resulting software. For this purpose, we consider open source project management and game software. We apply linear regression and cross validation techniques to investigate the relation between the sizes of problem domain (i.e., conceptual) and solution domain (i.e., design) models. The results reveal a high correlation between the number of conceptual classes in the problem domain model and the number of software classes constituting the corresponding software. The results suggest that it is possible to use problem domain descriptions in the early stages of software development projects to make plausible predictions for the size of the software.Item A Local Search Heuristic with Self-tuning Parameter for Permutation Flow-Shop Scheduling Problem(2009) Dengiz, Berna; Alabas-Uslu, Cigdem; Sabuncuoglu, IhsanIn this paper, a new local search metaheuristic is proposed for the permutation flow-shop scheduling problem. In general, metaheuristics are widely used to solve this problem due to its NP-completeness. Although these heuristics are quite effective to solve the problem, they suffer from the need to optimize parameters. The proposed heuristic, named STLS, has a single self-tuning parameter which is calculated and updated dynamically based on both the response surface information of the problem field and the performance measure of the method throughout the search process. Especially, application simplicity of the algorithm is attractive for the users. Results of the experimental study show that STLS generates high quality solutions and outperforms the basic tabu search, simulated annealing, and record-to-record travel algorithms which are well-known local search based metaheuristics.Item Individual Factors Leading To Delay In Diagnosis In Patients With Colorectal Cancer And Their Illness Perceptions(2022) Tanrikulu, U. Ege; Kav, S.Item Patient-Reported Outcomes (Pros) Of Cemiplimab Vs Chemotherapy In Advanced Non-Small Cell Lung Cancer (Ansclc): EMPOWER-Lung 1 Histology Subgroups(2022) Sezer, A.; Kilickap, S.; Gumus, M.; Bondarenko, I.; Ozguroglu, M.; Gogishvili, M.; He, X.; Gullo, G.; Rietschel, P.; Quek, R.Item Three Years Survival Outcome And Continued Cemiplimab (CEMI) Beyond Progression With The Addition Of Chemotherapy (Chemo) For Patients (Pts) With Advanced Non-Small Cell Lung Cancer (NSCLC): The EMPOWER-Lung 1 Trial(2022) Ozguroglu, M.; Kilickap, S.; Sezer, A.; Gumus, M.; Bondarenko, I.; Gogishvili, M.; Nechaeva, M.; Schenker, M.; Cicin, I.; Ho, G. F.; Kulyaba, Y.; Dvorkin, M.; Zyuhal, K.; Scheusan, R. I.; Li, S.; Pouliot, J-F.; Seebach, F.; Lowy, I.; Gullo, G.; Rietschel, P.Item ENGOT-Ov65/KEYNOTE-B96: Phase III, Randomized, Double-Blind Study Of Pembrolizumab Vs Placebo Plus Paclitaxel With Optional Bevacizumab For Platinum-Resistant Recurrent Ovarian Cancer(2022) Colombo, N.; Coleman, R. L.; Wu, X.; Kose, F.; Wenham, R.; Sebastianelli, A.; Hasegawa, K.; Zsiros, E.; Rouge, T. De La Motte; Bidzinski, M.; McNeish, I.; Sehouli, J.; Korach, J.; Debruyne, P. R.; Kim, J-W.; De Melo, A. C.; Peng, X.; Bogusz, A. M.; Yamada, K.; Monk, B. J.Item Patient-Reported Outcomes (Pros) With First-Line (1L) Cemiplimab In Patients With Locally Advanced Non-Small Cell Lung Cancer (Lansclc): EMPOWER-Lung 1 Subpopulation(2022) Bondarenko, I.; Sezer, A.; Kilickap, S.; Gumus, M.; Ozguroglu, M.; Gogishvili, M.; He, X.; Gullo, G.; Rietschel, P.; Quek, R. G.Item V-054 Laparoscopic Repair Of Two Cases With Obturator Hernia; Early Daignosed And Successful Results(2022) Tirnova, I; Yarbug Karakayali, F.; Karaca, A. S.; Fili, A., IItem A Systematic Review Of Current Rheumatology Guidelines For Geriatric Perspectives(2022) Bitik, B.; Tezcan, M. E.; Yucel, A. E.Item Survival After Recurrence in Early-Stage Cervical Cancer Patients(2021) Van Lonkhuijzen, L.; Dostalek, L.; Jarkovsky, J.; Lopez, A.; Falconer, H.; Scambia, G.; Ayhan, A.; Kim, S.; Isla Ortiz, D.; Klat, J.; Obermair, A.; Martino, Gdi; Pareja, R.; Manchanda, R.; Kostun, J.; Dos Reis, R.; Zapardiel, I.; Weinberger, V.; Cibula, D.